Atlas Trials

Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Clinical trial NCT00090974 · COMPLETED

Trial details

NCT number
NCT00090974
Sponsor
Eastern Cooperative Oncology Group
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2005-01-26
Primary completion
2013-01-30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.